Page last updated: 2024-10-27

fenofibrate and Anti-Glomerular Basement Membrane Disease

fenofibrate has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Anti-Glomerular Basement Membrane Disease: An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okabayashi, Y1
Nagasaka, S1
Kanzaki, G1
Tsuboi, N1
Yokoo, T1
Shimizu, A1

Other Studies

1 other study available for fenofibrate and Anti-Glomerular Basement Membrane Disease

ArticleYear
Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor α.
    Kidney international, 2019, Volume: 96, Issue:4

    Topics: Animals; Anti-Glomerular Basement Membrane Disease; Biopsy; CD8 Antigens; Cells, Cultured; Chemokine

2019